Delivery devices for treatment of vascular disease
CA 2408754 C · Owner: Cordis Corporation · Inventors: Falotico, Robert; Kopia, Gregory A.; Narayanan, Pallassana V.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An intralumen medical device comprising anti-proliferative and anti-thrombotic or anti-coagulant drugs, agents or compounds may be utilized in the treatment of vascular disease. The intralumen medical device is selectively coated with the drugs, agents or compounds for local delivery thereby increasing their , effectiveness and reducing potential toxicity associated with systemic use. The selective coating is utilized to ensure that the specific drugs agents or , compounds come into contact with or are delivered to the appropriate tissues and/or fluids for maximum effectiveness.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 14, 2001 and granted January 4, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 14, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 14, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.